SANTONI, MEDARDO
 Distribuzione geografica
Continente #
AS - Asia 197
NA - Nord America 194
EU - Europa 125
AF - Africa 18
SA - Sud America 14
Totale 548
Nazione #
US - Stati Uniti d'America 191
SG - Singapore 89
CN - Cina 46
SE - Svezia 30
DE - Germania 24
VN - Vietnam 21
IT - Italia 18
HK - Hong Kong 16
IN - India 15
BR - Brasile 12
IE - Irlanda 12
GB - Regno Unito 10
RU - Federazione Russa 10
SC - Seychelles 8
CI - Costa d'Avorio 6
NL - Olanda 6
CH - Svizzera 4
ID - Indonesia 4
AT - Austria 3
CA - Canada 3
FI - Finlandia 3
TG - Togo 3
AR - Argentina 2
FR - Francia 2
JO - Giordania 2
BD - Bangladesh 1
ES - Italia 1
GR - Grecia 1
JP - Giappone 1
NG - Nigeria 1
PL - Polonia 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 548
Città #
Singapore 60
Chandler 25
Santa Clara 21
Ashburn 20
Hong Kong 16
Beijing 15
Dublin 12
Fairfield 12
Southend 8
Boardman 7
Princeton 7
Abidjan 6
Turin 6
Cambridge 5
Hanoi 5
Bologna 4
Los Angeles 4
Ann Arbor 3
Berlin 3
Bern 3
Bühl 3
Haiphong 3
Ho Chi Minh City 3
Lomé 3
Munich 3
San Diego 3
Seattle 3
Amman 2
Frankfurt am Main 2
Guangzhou 2
Helsinki 2
Houston 2
Jinan 2
North Kuta 2
Phoenix 2
Redondo Beach 2
Shanghai 2
Shenyang 2
São Paulo 2
Toronto 2
Vienna 2
Abeokuta 1
Araci 1
Athens 1
Baoding 1
Buenos Aires 1
Buffalo 1
Bình Phước 1
Cedar Knolls 1
Dallas 1
Des Moines 1
Falkenstein 1
Florence 1
Fortaleza 1
Fuzhou 1
Hangzhou 1
Hebei 1
Jinzhong 1
Kilburn 1
Kuban 1
La Plata 1
Lajeado 1
Langfang 1
Lanzhou 1
Lauterbourg 1
London 1
Mascote 1
Milan 1
Monmouth Junction 1
Montreal 1
Ninh Bình 1
Nova Granada 1
Nuremberg 1
Osasco 1
Phú Thọ 1
Quảng Ngãi 1
Quận Bốn 1
Quận Ninh Kiều 1
Quận Phú Nhuận 1
Raleigh 1
Redmond 1
Redwood City 1
Rio de Janeiro 1
Riyadh 1
Salt Lake City 1
Santo Antônio do Jacinto 1
Santos 1
Suzhou 1
São Carlos 1
Taizhou 1
Thanh Hóa 1
Tokyo 1
Turku 1
Volgograd 1
Warsaw 1
Westminster 1
Wilmington 1
Woodbridge 1
Wuhan 1
Xi'an 1
Totale 350
Nome #
The human microbiota and prostate cancer: Friend or foe? 123
Tumor growth rate decline despite progressive disease may predict improved nivolumab treatment outcome in mrcc: When recist is not enough 103
Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis 99
Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: A systematic review 87
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials 77
Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials 72
Totale 561
Categoria #
all - tutte 2.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 6 0 0 1
2021/202280 0 1 2 1 2 0 0 21 8 2 30 13
2022/2023120 4 14 8 15 9 13 3 5 30 3 13 3
2023/202428 3 6 1 4 2 1 1 2 0 5 2 1
2024/2025158 15 29 13 16 24 8 11 5 3 8 4 22
2025/2026138 25 26 17 16 47 7 0 0 0 0 0 0
Totale 561